AC-0740

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameAC-0740
Drug Alias NameEGFR inhibitor (ACEA Pharma)AC-0740
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasm MetastasisLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Acea Pharmaceutical Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Acea Pharmaceutical Research Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A